{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:20:20Z","timestamp":1787160020354,"version":"build-2736575974"},"posted":{"date-parts":[[2025,11,17]]},"group-title":"Neuroscience","reference-count":51,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"NIH","award":["AA021667"],"award-info":[{"award-number":["AA021667"]}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"crossref","award":["T32 AA007456"],"award-info":[{"award-number":["T32 AA007456"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,11,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Sphingosine-1-phosphate (S1P) is a lipid mediator signaling through broadly expressed G protein-coupled receptors. We found that S1P is regulated by alcohol and that S1P receptor agonists reduce alcohol drinking in rodent models. Specifically, we observed that two S1P receptor agonists FDA-approved for multiple sclerosis, fingolimod and ozanimod, and the more brain penetrant S1P\n                  <jats:sub>1<\/jats:sub>\n                  receptor agonist CYM5442, reduced binge alcohol drinking in the drinking in the dark (DID) paradigm in mice. CYM5442 also reduced drinking in dependent mice in the chronic intermittent ethanol vapor paradigm of dependence-induced increased drinking paired with 2 bottle-choice (CIE-2BC) as well as in non-dependent mice. CYM5442 reduced operant oral alcohol self-administration in both non-dependent and dependent rats made dependent by vapor exposure, and reduced motivation for alcohol in dependent rats tested in a progressive ratio schedule of reinforcement. CYM5442 significantly prevented cue-induced reinstatement in alcohol-dependent rats, a model of relapse to alcohol seeking. CYM5442 also reduced intake of non-drug reinforcers, including sucrose, food, water and, to a lesser extent, saccharine. Notably, CYM5442 was less aversive than naltrexone, an FDA-approved medication for the treatment of alcohol use disorder that shares a similar broad reducing action on alcohol intake and consummatory behavior. CYM5442 had no effect on loss of righting reflex, alcohol metabolism, motor coordination or spontaneous locomotor activity in rodents. Lastly, gene expression analysis by RNA-Seq revealed that S1P regulates a complex set of genes in the transition to alcohol dependence. Overall, our results establish S1P signaling as a novel therapeutic target for alcohol use disorder.\n                <\/jats:p>","DOI":"10.1101\/2025.11.15.688635","type":"posted-content","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T16:40:20Z","timestamp":1763397620000},"source":"Crossref","is-referenced-by-count":2,"title":["Sphingosine-1-phosphate (S1P) signaling as a novel therapeutic target for alcohol abuse"],"prefix":"10.64898","author":[{"given":"Irene","family":"Lorrai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Maccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Shankula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Marquez-Gaytan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzamar","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Puliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vez","family":"Repunte-Canonigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Paolo","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025112002300582000_2025.11.15.688635v1.1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12669"},{"key":"2025112002300582000_2025.11.15.688635v1.2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/08897077.2015.1133472","article-title":"Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety","volume":"37","year":"2016","journal-title":"Subst Abus"},{"key":"2025112002300582000_2025.11.15.688635v1.3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/acer.14233","article-title":"Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice","volume":"44","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"2025112002300582000_2025.11.15.688635v1.4","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbamem.2017.03.008","article-title":"Sphingosine 1-phosphate - A double edged sword in the brain","volume":"1859","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"2025112002300582000_2025.11.15.688635v1.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04755.x"},{"key":"2025112002300582000_2025.11.15.688635v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)01551-1"},{"key":"2025112002300582000_2025.11.15.688635v1.7","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R046300"},{"key":"2025112002300582000_2025.11.15.688635v1.8","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7420com"},{"key":"2025112002300582000_2025.11.15.688635v1.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0882-x"},{"key":"2025112002300582000_2025.11.15.688635v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05030-w"},{"key":"2025112002300582000_2025.11.15.688635v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03674-2"},{"key":"2025112002300582000_2025.11.15.688635v1.12","doi-asserted-by":"publisher","DOI":"10.1124\/mol.112.082958"},{"key":"2025112002300582000_2025.11.15.688635v1.13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76369"},{"key":"2025112002300582000_2025.11.15.688635v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00244-0"},{"key":"2025112002300582000_2025.11.15.688635v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2004.10.007"},{"key":"2025112002300582000_2025.11.15.688635v1.16","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.049783"},{"key":"2025112002300582000_2025.11.15.688635v1.17","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000149977.95306.3A"},{"key":"2025112002300582000_2025.11.15.688635v1.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00379.x"},{"key":"2025112002300582000_2025.11.15.688635v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2004.04.002"},{"issue":"4228","key":"2025112002300582000_2025.11.15.688635v1.20","first-page":"4231","article-title":"Alcohol-induced cognitive impairment is reversible. Neuropsychological tests but not MRT show improvement after abstinence","volume":"95","year":"1998","journal-title":"Lakartidningen"},{"key":"2025112002300582000_2025.11.15.688635v1.21","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.10020233"},{"key":"2025112002300582000_2025.11.15.688635v1.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03106.x"},{"key":"2025112002300582000_2025.11.15.688635v1.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2000.tb02032.x"},{"key":"2025112002300582000_2025.11.15.688635v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.03.005"},{"key":"2025112002300582000_2025.11.15.688635v1.25","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0623-13.2014"},{"key":"2025112002300582000_2025.11.15.688635v1.26","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00149.x"},{"key":"2025112002300582000_2025.11.15.688635v1.27","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005492"},{"key":"2025112002300582000_2025.11.15.688635v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2009.110"},{"key":"2025112002300582000_2025.11.15.688635v1.29","doi-asserted-by":"crossref","first-page":"e0139012","DOI":"10.1371\/journal.pone.0139012","article-title":"Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"2025112002300582000_2025.11.15.688635v1.30","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00492"},{"issue":"4228","key":"2025112002300582000_2025.11.15.688635v1.31","first-page":"4231","article-title":"[Alcohol-induced cognitive impairment is reversible. Neuropsychological tests but not MRT show improvement after abstinence]","volume":"95","year":"1998","journal-title":"Lakartidningen"},{"key":"2025112002300582000_2025.11.15.688635v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUROPHARM.2017.01.012"},{"key":"2025112002300582000_2025.11.15.688635v1.33","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2243-09.2009"},{"key":"2025112002300582000_2025.11.15.688635v1.34","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2014.00301"},{"key":"2025112002300582000_2025.11.15.688635v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2010.01.011"},{"key":"2025112002300582000_2025.11.15.688635v1.36","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2012_202"},{"key":"2025112002300582000_2025.11.15.688635v1.37","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000553"},{"key":"2025112002300582000_2025.11.15.688635v1.38","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.041350"},{"key":"2025112002300582000_2025.11.15.688635v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.07.013"},{"key":"2025112002300582000_2025.11.15.688635v1.40","first-page":"8057045","article-title":"A Case of Parvovirus-Related Haemophagocytic Lymphohistiocytosis in a Patient with HbH Disease","volume":"2018","year":"2018","journal-title":"Case Rep Med"},{"key":"2025112002300582000_2025.11.15.688635v1.41","doi-asserted-by":"publisher","DOI":"10.1124\/mol.105.020552"},{"key":"2025112002300582000_2025.11.15.688635v1.42","doi-asserted-by":"crossref","first-page":"2633105520975412","DOI":"10.1177\/2633105520975412","article-title":"Effects of Tacrolimus and Other Immune Targeting Compounds on Binge-Like Ethanol Drinking in High Drinking in the Dark Mice","volume":"15","year":"2020","journal-title":"Neurosci Insights"},{"key":"2025112002300582000_2025.11.15.688635v1.43","doi-asserted-by":"crossref","unstructured":"Chuong V , Farokhnia M , Khom S , Pince CL , Elvig SK , Vlkolinsky R , Marchette RC , Koob GF , Roberto M , Vendruscolo LF , Leggio L. 2023. The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission. JCI Insight 8.","DOI":"10.1172\/jci.insight.170671"},{"key":"2025112002300582000_2025.11.15.688635v1.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2012.01031.x"},{"key":"2025112002300582000_2025.11.15.688635v1.45","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.2.269"},{"key":"2025112002300582000_2025.11.15.688635v1.46","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/34.3.386"},{"key":"2025112002300582000_2025.11.15.688635v1.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2010.01334.x"},{"key":"2025112002300582000_2025.11.15.688635v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2017.130"},{"key":"2025112002300582000_2025.11.15.688635v1.49","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00545"},{"key":"2025112002300582000_2025.11.15.688635v1.50","first-page":"142","article-title":"Hypothalamic S1P\/S1PR1 axis controls energy homeostasis in Middle-Aged Rodents: the reversal effects of physical exercise","volume":"9","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"2025112002300582000_2025.11.15.688635v1.51","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1038\/ncomms5859","article-title":"Hypothalamic S1P\/S1PR1 axis controls energy homeostasis","volume":"5","year":"2014","journal-title":"Nat Commun"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.11.15.688635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:02:52Z","timestamp":1768471372000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.11.15.688635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1101\/2025.11.15.688635","relation":{},"subject":[],"published":{"date-parts":[[2025,11,17]]},"subtype":"preprint"}}